| 1 |
Pashley DH. Dynamics of the pulpo-dentin complex [J]. Crit Rev Oral Biol Med, 1996, 7(2): 104-133.
|
| 2 |
Sengupta K, Christensen LB, Mortensen LH, et al. Trends in socioeconomic inequalities in oral health among 15-year-old Danish adolescents during 1995-2013: a nationwide, register-based, repeated cross-sectional study [J]. Community Dent Oral Epidemiol, 2017, 45(5): 458-468.
|
| 3 |
Farges JC, Alliot-Licht B, Renard E, et al. Dental pulp defence and repair mechanisms in dental caries [J]. Mediators Inflamm, 2015, 2015: 230251.
|
| 4 |
Choi BD, Jeong SJ, Wang G, et al. Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection [J]. J Endod, 2009, 35(7): 997-1002.
|
| 5 |
Lai WY, Kao CT, Hung CJ, et al. An evaluation of the inflammatory response of lipopolysaccharide-treated primary dental pulp cells with regard to calcium silicate-based cements [J]. Int J Oral Sci, 2014, 6(2): 94-98.
|
| 6 |
Murray PE, About I, Lumley PJ, et al. Human odontoblast cell numbers after dental injury [J]. J Dent, 2000, 28(4): 277-285.
|
| 7 |
Simon S, Smith AJ, Lumley PJ, et al. Molecular characterization of young and mature odontoblasts [J]. Bone, 2009, 45(4): 693-703.
|
| 8 |
Barthel CR, Rosenkranz B, Leuenberg A, et al. Pulp capping of carious exposures: treatment outcome after 5 and 10 years: a retrospective study [J]. J Endod, 2000, 26(9): 525-528.
|
| 9 |
Schmalz G, Smith AJ. Pulp development, repair, and regeneration: challenges of the transition from traditional dentistry to biologically based therapies [J]. J Endod, 2014, 40(4 Suppl): S2-S5.
|
| 10 |
Taha NA, Abdelkhader SZ. Outcome of full pulpotomy using Biodentine in adult patients with symptoms indicative of irreversible pulpitis [J]. Int Endod J, 2018 , 51(8): 819-828.
|
| 11 |
Ferracane JL, Cooper PR, Smith AJ. Can interaction of materials with the dentin-pulp complex contribute to dentin regeneration? [J]. Odontology, 2010, 98(1): 2-14.
|
| 12 |
ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome [J]. Nature, 2012, 489(7414): 57-74.
|
| 13 |
Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells [J]. Nature, 2012 , 489(7414): 101-108.
|
| 14 |
Kaikkonen MU, Lam MT, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics [J]. Cardiovasc Res, 2011, 90(3): 430-440.
|
| 15 |
Peschansky VJ, Wahlestedt C. Non-coding RNAs as direct and indirect modulators of epigenetic regulation [J]. Epigenetics, 2014, 9(1): 3-12.
|
| 16 |
Xu S, Kamato D, Little PJ, et al. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics [J]. Pharmacol Ther, Epub 2018 Nov 13.
|
| 17 |
Tsikou D, Yan Z, Holt DB, et al. Markmann K. Systemic control of legume susceptibility to rhizobial infection by a mobile microRNA [J]. Science, 2018, 362(6411): 233-236.
|
| 18 |
Palazzo AF, Lee ES. Non-coding RNA: what is functional and what is junk? [J]. Front Genet, 2015, 6: 2.
|
| 19 |
Ricucci D, Loghin S, Siqueira JF Jr. Correlation between clinical and histologic pulp diagnoses [J]. J Endod, 2014, 40(12): 1932-1939.
|
| 20 |
Mente J, Petrovic J, Gehrig H, et al. A prospective clinical pilot study on the level of matrix metalloproteinase-9 in dental pulpal blood as a marker for the state of inflammation in the pulp tissue [J]. J Endod, 2016, 42(2): 190-197.
|
| 21 |
Rechenberg DK, Galicia JC, Peters OA. Biological markers for pulpal inflammation: a systematic review [J]. PLoS One, 2016, 11(11): e0167289.
|
| 22 |
Schönauen K, Le N, von Arnim U, et al. Circulating and fecal microRNAs as biomarkers for inflammatory bowel diseases [J]. Inflamm Bowel Dis, 2018, 24(7): 1547-1557.
|
| 23 |
Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges [J]. Nat Rev Drug Discov, 2014, 13(8): 622-638.
|
| 24 |
Carpenter S, Aiello D, Atianand MK, et al. A long noncoding RNA mediates both activation and repression of immune response genes [J]. Science, 2013, 341(6147): 789-792.
|
| 25 |
Jenuwein T, Allis CD. Translating the histone code [J]. Science, 2001, 293(5532): 1074-1080.
|
| 26 |
Ambros V. The functions of animal microRNAs [J]. Nature, 2004, 431(7006): 350-355.
|
| 27 |
Bayarsaihan D. Epigenetic mechanisms in inflammation [J]. J Dent Res, 2011, 90(1): 9-17.
|
| 28 |
Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs [J]. Cell, 2009, 136(4): 642-655.
|
| 29 |
Braicu C, Cojocneanu-Petric R, Chira S, et al. Clinical and pathological implications of miRNA in bladder cancer [J]. Int J Nanomedicine, 2015, 10: 791-800.
|
| 30 |
Ling H, Pickard K, Ivan C, et al. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis [J]. Gut, 2016, 65(6): 977-989.
|
| 31 |
Pop-Bica C, Gulei D, Cojocneanu-Petric R, et al. Understanding the role of non-coding RNAs in bladder cancer: From Dark Matter to Valuable Therapeutic Targets [J]. Int J Mol Sci, 2017, 18(7). pii: E1514.
|
| 32 |
O′Connell RM, Taganov KD, Boldin MP, et al. MicroRNA-155 is induced during the macrophage inflammatory response [J]. Proc Natl Acad Sci U S A, 2007, 104(5): 1604-1609.
|
| 33 |
Liu G, Friggeri A, Yang Y, et al. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses [J]. Proc Natl Acad Sci U S A, 2009, 106(37): 15819-15824.
|
| 34 |
Zhong S, Zhang S, Bair E, et al. Differential expression of microRNAs in normal and inflamed human pulps [J]. J Endod, 2012, 38(6): 746-752.
|
| 35 |
Liu X, Zhan Z, Xu L, et al. MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα [J]. J Immunol, 2010, 185(12): 7244-7251.
|
| 36 |
Pichiorri F, Suh SS, Ladetto M, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis [J]. Proc Natl Acad Sci U S A, 2008, 105(35): 12885-12890.
|
| 37 |
Dave RS, Khalili K. Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system [J]. J Cell Biochem, 2010, 110(4): 834-845.
|
| 38 |
Xue Q, Guo ZY, Li W, et al. Human activated CD4(＋) T lymphocytes increase IL-2 expression by downregulating microRNA-181c [J]. Mol Immunol, 2011, 48(4): 592-599.
|
| 39 |
Wang B, Hsu SH, Majumder S, et al. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 [J]. Oncogene, 2010, 29(12): 1787-1797.
|
| 40 |
Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA [J]. N Engl J Med, 2013, 368(18): 1685-1694.
|
| 41 |
van der Ree MH, van der Meer AJ, de Bruijne J, et al. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients [J]. Antiviral Res, 2014, 111: 53-59.
|
| 42 |
Irimie AI, Braicu C, Sonea L, et al. A looking-glass of non-coding RNAs in oral cancer [J]. Int J Mol Sci, 2017, 18(12). pii: E2620.
|
| 43 |
Irimie AI, Braicu C, Pileczki V, et al. Knocking down of p53 triggers apoptosis and autophagy, concomitantly with inhibition of migration on SSC-4 oral squamous carcinoma cells [J]. Mol Cell Biochem, 2016, 419(1-2): 75-82.
|
| 44 |
Jurj A, Braicu C, Pop LA, et al. The new era of nanotechnology, an alternative to change cancer treatment [J]. Drug Des Devel Ther, 2017, 11: 2871-2890.
|
| 45 |
Haussecker D, Kay MA. RNA interference. Drugging RNAi [J]. Science, 2015, 347(6226): 1069-1070.
|
| 46 |
Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects [J]. Chem Biol, 2012, 19(1): 60-71.
|
| 47 |
Wu H, He M, Yang R, et al. Astrocyte elevated gene-1 participates in the production of pro-inflammatory cytokines in dental pulp cells via NF-κB signalling pathway [J]. Int Endod J, 2018, 51(10): 1130-1138.
|
| 48 |
Huang Y, Qiao W, Wang X, et al. Role of Ku70 in the apoptosis of inflamed dental pulp stem cells [J]. Inflamm Res, 2018, 67(9): 777-788.
|
| 49 |
Hui T, A P, Zhao Y, et al. EZH2 regulates dental pulp inflammation by direct effect on inflammatory factors [J]. Arch Oral Biol, 2018, 85: 16-22.
|
| 50 |
Bei Y, Tianqian H, Fanyuan Y, et al. ASH1L suppresses matrix metalloproteinase through mitogen-activated protein kinase signaling pathway in pulpitis [J]. J Endod, 2017, 43(2): 306-314.
|
| 51 |
IIott NE, Heward JA, Roux B, et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes [J]. Nat commun, 2014, 5: 3979.
|
| 52 |
Wang P, Xue Y, Han Y, et al. The STAT3-binding long noncoding RNA lnc-DC controls human dendritic cell differentiation [J]. Science, 2014, 344(6181): 310-313.
|
| 53 |
Tripathi V, Shen Z, Chakraborty A, et al. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB [J]. PLoS Genet, 2013, 9(3): e1003368.
|
| 54 |
Hirose T, Virnicchi G, Tanigawa A, et al. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies [J]. Mol Biol cell, 2014, 25(1): 169-183.
|
| 55 |
Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future [J]. Genetics, 2013, 193(3): 651-669.
|
| 56 |
Huang X, Chen K. Differential expression of long noncoding RNAs in normal and inflamed human dental pulp [J]. J Endod, 2018, 44(1): 62-72.
|
| 57 |
Chen L, Song Z, Huang S, et al. LncRNA DANCR suppresses odontoblast-like differentiation of human dental pulp cells by inhibiting wnt/β-catenin pathway [J]. Cell Tissue Res, 2016, 364(2): 309-318.
|
| 58 |
Zeng L, Sun S, Han D, et al. Long non-coding RNA H19/SAHH axis epigenetically regulates odontogenic differentiation of human dental pulp stem cells [J]. Cell Signal, 2018, 52: 65-73.
|